Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 18551-18600 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06990438
Effect of Long-Term Use of Tenofovir (TDF) on Bone Density in Patients With Chronic Hepatitis B
N/A
Not yet recruiting
172 participants
Started: May 22, 2025 · Completed: Jun 1, 2026
3 conditions
1 sponsor
1 location
NCT06882811
Human Umbilical Cord Mesenchymal Stem Cells Treatment in Sepsis
EARLY_PHASE1
Recruiting
180 participants
Started: May 22, 2025 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT06682793
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
PHASE1/PHASE2
Recruiting
240 participants
Started: May 22, 2025 · Completed: Mar 31, 2030
17 conditions
1 sponsor
10 locations
NCT07002060
Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults
PHASE3
Active, not recruiting
640 participants
Started: May 22, 2025 · Completed: Jan 8, 2026
1 condition
1 sponsor
7 locations
NCT07017374
Proteomic Analysis of Serum Samples After Cardiac Arrest: a TTM-trial Substudy
N/A
Active, not recruiting
682 participants
Started: May 22, 2025 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT06491537
Time-restricted Eating for Postpartum Weight Loss
NA
Recruiting
60 participants
Started: May 22, 2025 · Completed: Feb 1, 2029
2 conditions
2 sponsors
1 location
NCT06954662
A Targeted Amino Acid Supplement for People With Parkinson's Disease
EARLY_PHASE1
Active, not recruiting
15 participants
Started: May 22, 2025 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT06942143
An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1-positive Patients With Advanced Solid Tumors
PHASE1
Recruiting
15 participants
Started: May 22, 2025 · Completed: Jun 25, 2027
3 conditions
2 sponsors
1 location
NCT06975878
Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
PHASE3
Recruiting
1,080 participants
Started: May 22, 2025 · Completed: Aug 18, 2027
2 conditions
1 sponsor
32 locations
NCT06616584
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
PHASE2/PHASE3
Recruiting
378 participants
Started: May 22, 2025 · Completed: Dec 31, 2028
2 conditions
3 sponsors
239 locations
NCT06879912
A Study to Understand the Utility of the Force Feedback Instruments in Robotic Procedures Using da Vinci 5 Robot
N/A
Recruiting
200 participants
Started: May 22, 2025 · Completed: Aug 31, 2026
6 conditions
1 sponsor
2 locations
NCT06983041
Clinical Study of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (VVC)
NA
Recruiting
55 participants
Started: May 22, 2025 · Completed: Dec 31, 2025
2 conditions
1 sponsor
5 locations
NCT06880354
A Clinical Study to Evaluate the Safety and Efficacy of CLL1 and CD38 Dual-Target CAR-T Cell Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
PHASE1
Recruiting
37 participants
Started: May 22, 2025 · Completed: Mar 31, 2028
1 condition
3 sponsors
1 location
NCT07062562
The Effect of Repeated Whole-body NMES Sessions With or Without Protein Intake on Muscle Protein Synthesis During 3 Days of Bed Rest in Healthy Young Volunteers
NA
Recruiting
42 participants
Started: May 22, 2025 · Completed: May 31, 2027
1 condition
1 sponsor
1 location
NCT07035041
A Phase 2 Study of D-2570 in Subjects With Moderately to Severely Active Ulcerative Colitis
PHASE2
Recruiting
120 participants
Started: May 22, 2025 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT06974929
A Clinical Study of HRS-6209 in Combination With Letrozole in Patients With Breast Cancer
PHASE1/PHASE2
Recruiting
80 participants
Started: May 22, 2025 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06940596
Exclude or Expose in Irritable Bowel Syndrome: What Works for Whom and How?
NA
Recruiting
200 participants
Started: May 22, 2025 · Completed: Jul 31, 2027
3 conditions
2 sponsors
1 location
NCT06789159
A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL)
PHASE1
Recruiting
30 participants
Started: May 22, 2025 · Completed: Oct 1, 2028
3 conditions
3 sponsors
1 location
NCT06931951
The Effectiveness and Safety of Pharmacopuncture on Inpatients With Acute Knee Pain Caused by Traffic Accidents
NA
Recruiting
40 participants
Started: May 22, 2025 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06952504
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
PHASE3
Recruiting
1,123 participants
Started: May 22, 2025 · Completed: May 24, 2032
1 condition
1 sponsor
141 locations
NCT06814080
Residual Gastric Content and GLP-1
N/A
Recruiting
45 participants
Started: May 22, 2025 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT06996613
Liberal Versus Restrictive Transfusion Strategy in Patients With Upper Git Bleeding
N/A
Not yet recruiting
200 participants
Started: May 22, 2025 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT06964620
Efficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 Diabetes
EARLY_PHASE1
Recruiting
84 participants
Started: May 22, 2025 · Completed: Dec 25, 2027
2 conditions
1 sponsor
1 location
NCT06951438
Assessing Acceptability and Feasibiity of STI Self-swab Testing, to be Offered at the Time of Telemed Medication Abortion Provision
NA
Recruiting
75 participants
Started: May 22, 2025 · Completed: Jun 30, 2026
4 conditions
2 sponsors
1 location
NCT05086432
Sputum Cytometry Guided Management for the Elimination of Chronic Cough in Patients With ILD
NA
Recruiting
120 participants
Started: May 22, 2025 · Completed: Mar 31, 2027
1 condition
3 sponsors
1 location
NCT06810583
A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
PHASE1
Recruiting
29 participants
Started: May 22, 2025 · Completed: Sep 30, 2030
3 conditions
1 sponsor
1 location
NCT06751784
Cross-over Study on the Influence of Fampridine on Working Memory in Mild Depression
PHASE2
Recruiting
38 participants
Started: May 22, 2025 · Completed: Jul 31, 2026
2 conditions
2 sponsors
1 location
NCT06915844
Integrated HPV Vaccination and Adolescent Health in Tanzania
NA
Active, not recruiting
3,000 participants
Started: May 22, 2025 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT05821478
Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients
PHASE3
Recruiting
92 participants
Started: May 22, 2025 · Completed: Feb 27, 2028
1 condition
5 sponsors
4 locations
NCT07032350
E-Tailored Pain Management Support for Dementia Family Caregivers: Feasibility of the PACE-app
NA
Recruiting
60 participants
Started: May 22, 2025 · Completed: May 31, 2026
5 conditions
2 sponsors
1 location
NCT06962800
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
PHASE3
Recruiting
180 participants
Started: May 22, 2025 · Completed: Mar 29, 2029
1 condition
1 sponsor
4 locations
NCT06912698
Reduced Dose Radiotherapy vs Standard Dose Radiotherapy for Early Stage Nasopharyngeal Carcinoma
PHASE3
Recruiting
342 participants
Started: May 22, 2025 · Completed: Mar 19, 2033
1 condition
1 sponsor
1 location
NCT06999356
Salud Diabetes: A Pilot Study Comparing Lifestyle Interventions and Real-Time Continuous Glucose Monitoring
NA
Recruiting
200 participants
Started: May 22, 2025 · Completed: May 31, 2026
2 conditions
2 sponsors
1 location
NCT06992128
Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial
PHASE2
Recruiting
129 participants
Started: May 22, 2025 · Completed: Aug 31, 2028
1 condition
12 sponsors
1 location
NCT06802003
Predicting Acute Exacerbations of COPD Using Wearable Devices and Remote Monitoring Technology With AI/ML Models
N/A
Recruiting
50 participants
Started: May 22, 2025 · Completed: Aug 31, 2026
2 conditions
2 sponsors
1 location
NCT06611501
Glycemic Regulation as Endometriosis Adjunct Treatment
PHASE2
Recruiting
14 participants
Started: May 22, 2025 · Completed: Jan 31, 2027
2 conditions
1 sponsor
1 location
NCT06614959
The Effects of Oscillatory Positive Expiratory Pressure (OPEP) Therapy in Patients With COPD
NA
Recruiting
32 participants
Started: May 22, 2025 · Completed: Sep 30, 2026
1 condition
2 sponsors
1 location
NCT06803056
QUANTIFY: Quantitative Understanding of Advanced Novel Techniques for Imaging Fasciitis and Yielding Biomarkers
NA
Recruiting
120 participants
Started: May 22, 2025 · Completed: Aug 31, 2026
3 conditions
3 sponsors
1 location
NCT06904326
CLUBE (UBE Stability / Dynamic Radio)
NA
Recruiting
400 participants
Started: May 22, 2025 · Completed: Aug 31, 2027
1 condition
1 sponsor
1 location
NCT06901531
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
PHASE3
Recruiting
500 participants
Started: May 22, 2025 · Completed: Dec 31, 2029
4 conditions
1 sponsor
78 locations
NCT06843590
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia
PHASE2
Recruiting
96 participants
Started: May 22, 2025 · Completed: Jun 30, 2026
1 condition
1 sponsor
40 locations
NCT06697301
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
PHASE2/PHASE3
Recruiting
740 participants
Started: May 22, 2025 · Completed: Dec 31, 2040
1 condition
2 sponsors
57 locations
NCT07030517
A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma
PHASE4
Recruiting
75 participants
Started: May 22, 2025 · Completed: Jun 20, 2027
1 condition
1 sponsor
8 locations
NCT06832631
VITUS Post-Market Registry
N/A
Recruiting
284 participants
Started: May 22, 2025 · Completed: Apr 30, 2029
2 conditions
3 sponsors
9 locations
NCT06742710
Liraglutide Treatment in Obese Infertile PCOS Women
PHASE4
Recruiting
890 participants
Started: May 22, 2025 · Completed: Dec 31, 2029
3 conditions
1 sponsor
3 locations
NCT06893887
Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma
NA
Recruiting
300 participants
Started: May 22, 2025 · Completed: Mar 15, 2028
1 condition
1 sponsor
1 location
NCT06999707
Photon Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC
PHASE2
Recruiting
45 participants
Started: May 22, 2025 · Completed: May 31, 2033
4 conditions
1 sponsor
1 location
NCT07023484
Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer
PHASE2
Recruiting
126 participants
Started: May 22, 2025 · Completed: Dec 31, 2028
3 conditions
6 sponsors
6 locations
NCT07024836
PRecision biomArker-Guided MAnagement of TuberculosIs Contacts: a Discrete Choice Experiment
N/A
Recruiting
430 participants
Started: May 22, 2025 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT07127198
Tolerance and Appetite Reduction of a Nutritional Solution With Intragastric Gelation Properties
NA
Recruiting
24 participants
Started: May 22, 2025 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
Previous
1
More pages
369
370
371
372
373
374
375
More pages
2369
Next